CRP and chronic kidney disease: When the studies were stratified into predialysis CKD patients or dialysis patients, statins use was associated with a significant decreased on CRP in the subgroup of studies with predialysis CKD patients (-2.95 mg/L; 95% CI: -4.90 to -0.99, p < 0.01, Figure 6) or with dialysis patients (-2.24 mg/L; 95% CI: -3.13 to -1.36, p < 0.01, Figure 6).